Medical Health & Life Science Research News

Diagnosis and management of Duchenne muscular dystrophy therapeutics in developing countries just published

Medical Market Research

The Report Duchenne Muscular Dystrophy Therapeutics Market focuses on major leading Market players, Key market segments and sub-segments to provide comprehensive and insightful data


Duchenne Muscular Dystrophy (DMD) is a fatal genetic disorders diagnosed in children around the world. DMD is often referred to as orphan or rare diseases, as it affects only a small portion of the population, approximately 1 in every 3,500 live male births.

However, various treatment approaches are available now-a-days that can inhibit progression of the disease. Amongst, the most attractive are molecular based therapies, such as mutation suppression or exon skipping.